FTRE (Fortrea Holdings) Payments of Debt: $-452 Mil (TTM As of Mar. 2026)


FTRE Fortrea Holdings Inc FTRE
64 GF Score
Price $17.02
GF Value $18.23
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Fortrea Holdings Payments of Debt?

Fortrea Holdings FTRE -2.58% 64 Payments of Debt is $-452 Mil as of Mar. 2026. GuruFocus rates FTRE with a GF Score™ of 64/100 and a GF Value™ of $18.23 (Fairly Valued). The stock has 7 warning signs investors should review.

Fortrea Holdings's Payments of Debt for the three months ended in Mar. 2026 was $0 Mil.

Fortrea Holdings's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was $-452 Mil.

Fortrea Holdings Payments of Debt Related Terms

Fortrea Holdings Payments of Debt Historical Data

* Premium members only.

The historical data trend for Fortrea Holdings's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortrea Holdings Payments of Debt Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial 0.00 0.00 -179.40 -1,309.20 -529.60

Fortrea Holdings Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -77.50 -188.90 -187.50 -75.70 0.00
FTRE
64GF Score
Fortrea Holdings Inc FTRE
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortrea Holdings Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-452 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-452 Mil mean?
Fortrea Holdings (FTRE) has a Payments of Debt of $-452 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Fortrea Holdings and its competitors.
Is Fortrea Holdings' Payments of Debt too high?
Fortrea Holdings' current Payments of Debt is $-452 Mil. Overall, Fortrea Holdings has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' Payments of Debt compare to SEPN and MLTX?
Fortrea Holdings' Payments of Debt of $-452 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Fortrea Holdings and its competitors. Fortrea Holdings's current Payments of Debt is $-452 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Based on GuruFocus' analysis, Fortrea Holdings (FTRE) is currently considered Fairly Valued. The stock's GF Value™ is $18.23, compared to a current price of $17.02 — trading 6.6% below its estimated fair value. The current Payments of Debt is $-452 Mil. Fortrea Holdings' overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Fortrea Holdings (FTRE), the current Payments of Debt is $-452 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortrea Holdings (FTRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fortrea Holdings stock appears to be undervalued. The current stock price of $17.02 is trading 6.6% below its estimated GF Value™ of $18.23. GuruFocus considers Fortrea Holdings to be Fairly Valued.

Key valuation signals for FTRE:

  • Payments of Debt: $-452 Mil
  • GF Value™: $18.23 vs. price of $17.02 (6.6% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the FTRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortrea Holdings Business Description

Other Exchanges K67:Germany
Address 8 Moore Drive, Durham, NC, USA, 27713
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
64GF Score

Get the complete analysis for FTRE

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.02
Price
$18.23
GF Value